Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
Ophthalmic CRO Services
Cyagen offers comprehensive ophthalmic CRO solutions, from custom animal models to drug administration and validation, ensuring efficient and reliable results throughout preclinical research.
One-Stop Full-service Preclinical Ophthalmology CRO Solutions
At Cyagen, a leading ophthalmology contract research organization (CRO), we leverage 20+ years of experience in gene therapy and advanced technical infrastructure to deliver end-to-end solutions. Our platform supports preclinical ophthalmic research and ocular drug development with a wide range of customized disease models, advanced in vivo drug administration, and comprehensive phenotyping. With a proven track record of delivering over 500 CRO projects and accelerating more than 20 IND applications, we ensure precise, efficient, and reliable results at every stage of your research.
{{ item.title }}
{{static_tabs[0].title}}
Cyagen offers an extensive collection of ophthalmic disease models, spanning genetic, humanized, and inducible types. The map below provides a visual overview of our available models categorized by disease area—helping you quickly identify the best-fit model for your study.
Search Genetic & Humanized Models
Use the filters below to search by disease, gene, or model type. All listed models are available for inquiry and can be customized based on your project needs.
Base Strain
Search for Models
Search
Catalog Number Name Base Strain Research Application Action
{{ value.product_num || "--" }} {{ value.product_name || "--" }} {{ value.product_strain || "--" }}
Inquire
+
Previous Page
Next Page
Explore Inducible and Surgical Models
In addition to genetic models, Cyagen provides a wide range of inducible and surgical models for studying complex ocular conditions. These models are widely used in pharmacological research, especially for evaluating intraocular drug delivery, retinal degeneration, and vascular responses.
Related Diseases Modeling Method Strain Background
Glaucoma Ischemia-Reperfusion-Induced Mouse
Glaucoma Magnetic Bead Occlusion-Induced Mouse & Rat
Glaucoma N-Methyl-D-Aspartate (NMDA)-Induced Mouse & Rat
Glaucoma Optic Nerve Crush Injury Mouse
Dry Eye Syndrome Benzalkonium Chloride (BAC)-Induced Mouse
Corneal Neovascularization Sodium Hydroxide (NaOH)-Induced Mouse & Rat
Wet AMD Laser-Induced Choroidal Neovascularization (CNV) Mouse & Rat
Dry AMD Sodium Iodate-Induced Mouse
Dry AMD Blue Light-Induced Mouse
Retinitis Pigmentosa (RP) N-Methyl-N-nitrosourea (MNU)-Induced Mouse & Rat
Retinoblastoma Y-79 Cells-Induced Mouse
Subretinal Fibrosis Laser-Induced Mouse & Rat
Traumatic Neuropathy Laser-Induced Mouse & Rat
Central Retinal Vein Occlusion (CRVO) Laser-Induced Mouse & Rat
Can't Find Your Model?
If your desired model isn't listed, our experts are here to help! Request a Custom Animal Model >>
{{static_tabs[1].title}}
At Cyagen, we offer advanced in vivo drug delivery and phenotyping services tailored for ophthalmic studies. From precise ocular injections to high-resolution imaging and vision behavior analysis, our platform provides comprehensive capabilities to evaluate drug efficacy and safety. Supported by expert personnel and cutting-edge instrumentation, we ensure consistent, accurate, and reproducible preclinical results.
Custom Injection Methods
  • Intracameral injection
  • Intravitreal injection
  • Subretinal injection
  • Subconjunctival injection
  • Retrobulbar injection
Our injection techniques ensure accurate localization and minimal variability, with an overall success rate exceeding 90%.
Non-Invasive Imaging
  • Fundus photography (FP)
  • Fundus autofluorescence (GFP/mCherry) imaging
  • Fundus fluorescein angiography (FFA)
  • Optical Coherence Tomography (OCT)
  • Laser photocoagulation
  • Slit-lamp biomicroscopy
  • Indirect ophthalmoscopy
  • Intraocular pressure (IOP) measurement
  • Flash electroretinogram (f-ERG)
  • Flash visual evoked potentials (f-VEP)
  • Corneal fluorescein staining
  • Corneal confocal microscopy examination
Vision Behavioral Testing
  • Visual optomotor response (OMR) test
  • Visual water maze test
  • Visual light/dark box test
  • Visual reflex assessment
Need tailored injection methods or behavioral assays for your ocular study?
Request Customized In Vivo Services >>
Case Examples
{{ item.label }}
{{v2.label}}
{{item.context}}
{{v2.context}}
{{item.title}}
{{ item.context }}
{{static_tabs[2].title}}
Verify treatment efficacy and mechanism of action through detailed tissue-level analysis and molecular assays. Cyagen provides end-to-end solutions for ocular histopathology, molecular profiling, and biomarker validation—supporting your IND filings with reliable, publication-ready data.
Tissue Collection & Preparation
  • Precise dissection of ocular tissues (including retina, RPE cells, cornea, iris, aqueous humor, lens, vitreous, optic nerve, choroid & sclera) in mice, rats, and/or rabbits
  • Specialized handling to preserve tissue structure and biomarker integrity for PK/PD studies
Histological Analysis
  • Paraffin sections and frozen sections
  • Flat-mount preparation of ocular tissues, including cornea, retina, and RPE–choroid complex
  • H&E staining, immunohistochemistry (IHC), and immunofluorescence (IF)
  • Morphological evaluation and pathology scoring
Molecular Assays
  • Western blotting for protein expression profiling
  • qPCR/RT-PCR for gene expression analysis
  • Droplet digital PCR (ddPCR) for ultra-sensitive absolute quantification
  • ELISA for cytokine and secreted protein measurement
  • Flow cytometry for multiparametric cell analysis and sorting
  • Supports biomarker discovery and mechanism validation
Need support for molecular and histological validation?
Request Custom Validation Services >>
Case Examples
{{ item.label }}
{{v2.label}}
{{item.context}}
{{v2.context}}
{{item.title}}
{{ item.context }}
Our Unique Advantages
Extensive Library of Validated Ocular Models
Cyagen offers a wide range of ready-to-use and customizable mouse models—including genetic, humanized, and induced types—covering major ocular diseases such as glaucoma, AMD, DR, and RP.
Full-Spectrum Efficacy Evaluation Platform
Our platform integrates precise ocular drug delivery, in vivo imaging (OCT/ERG/FFA), behavioral testing, and molecular pathology to deliver comprehensive efficacy evaluation.
Trusted CRO Partner for Translational Research
With 500+ projects completed and over 20 IND filings supported, Cyagen delivers reliable, publication-ready data that accelerates preclinical ophthalmic drug development.
Related Resources
Events & Webinars
Beyond the mouse: Accelerating Drug Discovery for Obesity & T2D with HUGO-GT™
View Details
Promotional Campaign
Flash Drop — Ready-to-Ship KO/cKO Mice
View Details
Blogs & Insights
Accelerating Alzheimer's Research Using Advanced iPSC Platforms
View Details
Resource Valut
Development of Fully Human Anti-ACVR2A Antibodies with Enhanced Selectivity and Favorable Pharmacokinetics for Metabolic and Muscle Disorders
View Details
Request a Preclinical CRO Services Consultation
Partner with Cyagen to advance your preclinical studies. Share your project goals with us and receive customized support.
Inquiry Details
Main Area of Research
Service(s) of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research